Synthesis, Bioproduction and Bioactivity of Perillic Acid—A Review
Molecules · 24.01.2025 · 30 (3) · 528
DOI: 10.3390/molecules30030528 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 24.01.2025. Verfasst von Thaís de Souza Rolim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Drug Technology, Fiocruz, Sizenando Nabuco St. 100, Manguinhos, Rio de Janeiro 21041-250, RJ, Brazil. Hauptthemen laut MEDLINE: Monoterpenes, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brazilian National Council for Scientific and Technological Development (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–Brasil CAPES.
Abstract (Originalsprache)
Perillic acid (PA) is a limonene derivative in which the exocyclic methyl is oxidized to a carboxyl group. Although endowed with potential anticancer activity, PA has been much less explored regarding its biological properties than analogous compounds such as perillyl alcohol, perillaldehyde, or limonene itself. PA is usually described in mixture with alcohols and ketones produced in the oxidation of monoterpenes, with relatively few existing reports focusing on the PA molecule. This study provides a comprehensive review of PA, addressing its origin, the processes of obtaining it through organic synthesis and biotransformation, and the pharmacological tests in which it is either the lead compound or reference for in vitro efficacy in experimental models. Although feasible and generally poorly yielded, the synthesis of PA from limonene requires multiple steps and the use of unusual catalysts. The most economical process involves using (−)-β-pinene epoxide as the starting material, ending up with (−)-PA. On the other hand, some bacteria and yeasts are successful in producing, exclusively or at satisfactory purity level, PA from limonene or a few other monoterpenes, through environmentally friendly approaches. The compiled data revealed that, with few exceptions, most reports on PA bioactivity are related to its ability to interfere with the prenylation process of oncogenic proteins, an essential step for the growth and dissemination of cancer cells. The present survey reveals that there is still a vast field to disclose regarding the obtaining and scaling of PA via the fermentative route, as well as extending prospective studies on its properties and possible pharmacological applications, especially in the preclinical oncology field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Drug Technology, Fiocruz, Sizenando Nabuco St. 100, Manguinhos, Rio de Janeiro 21041-250, RJ, Brazil.
- Rio de Janeiro Botanical Garden Research Institute, Pacheco Leão St. 915, Jardim Botânico, Rio de Janeiro 22460-030, RJ, Brazil.
ORCID-Profile: Thaís de Souza Rolim, Davyson Lima Moreira, Antonio Carlos Siani
Förderung
- Brazilian National Council for Scientific and Technological Development (CNPq)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–Brasil CAPES
Zitieren
APA
Rolim, T. S., Sampaio, A. L. F., Mazzei, J. L., Moreira, D. L., & Siani, A. C. (2025). Synthesis, Bioproduction and Bioactivity of Perillic Acid—A Review. Molecules, 30(3), 528. https://doi.org/10.3390/molecules30030528
Vancouver
Rolim TS, Sampaio ALF, Mazzei JL, Moreira DL, Siani AC. Synthesis, Bioproduction and Bioactivity of Perillic Acid—A Review. Molecules. 2025;30(3):528. doi:10.3390/molecules30030528
BibTeX
@article{Rolim2025,
author = {Rolim, Thaís de Souza and Sampaio, André Luiz Franco and Mazzei, José Luiz and Moreira, Davyson Lima and Siani, Antonio Carlos},
title = {Synthesis, Bioproduction and Bioactivity of Perillic Acid—A Review},
journal = {Molecules},
year = {2025},
volume = {30},
number = {3},
pages = {528},
doi = {10.3390/molecules30030528}
}
EUVIMED